BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Graham Companies Buys Miami Lakes Industrial Park, Occupied by HeartWare (HTWR) for $14.3 Million


6/27/2012 7:56:51 AM

South Florida Business Journal by Oscar Pedro Musibay, Reporter

The Graham Companies has bought the Miami Lakes Research & Industrial Park, an eight-building research and development manufacturing campus, for $14.3 million, or $49 per square foot.

CBRE represented the seller, MCP EWE, a joint venture between The Easton Group and Marcus Partners. The 290,529-square-foot campus is at 14400–14560 N.W. 60th Ave.

The property is currently only occupied by HeartWare (NASDAQ: HTWR), a bio-medical device company. A total of 131,000 square feet in four buildings is vacant, putting the campus at 45 percent occupancy.

Graham was the original developer of the property.

“Strong cash flow from the HeartWare lease helped offset vacancy concerns,” said associate Miguel Alcivar of CBRE’s Private Capital Group. “The Graham Companies’ inherent ties to the asset and experience with life sciences companies made them the most logical buyer.”

Alcivar was joined by Vice Chairman Christian Lee from CBRE’s Institutional Group and Senior Vice President Scott O'Donnell from CBRE's Private Capital Group in representing the seller.




HeartWare
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES